Phar Vision Advisers, LLC Grifols Sa Transaction History
Phar Vision Advisers, LLC
- $178 Billion
- Q3 2025
A detailed history of Phar Vision Advisers, LLC transactions in Grifols Sa stock. As of the latest transaction made, Phar Vision Advisers, LLC holds 34,831 shares of GRFS stock, worth $303,378. This represents 0.2% of its overall portfolio holdings.
Number of Shares
34,831Holding current value
$303,378% of portfolio
0.2%Shares
1 transactions
Others Institutions Holding GRFS
# of Institutions
200Shares Held
148MCall Options Held
76.1KPut Options Held
58.2K-
Brandes Investment Partners, LP La Jolla, CA29.1MShares$254 Million2.44% of portfolio
-
Capital World Investors Los Angeles, CA22.9MShares$200 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY17.5MShares$152 Million27.86% of portfolio
-
Black Creek Investment Management Inc. Toronto, A610MShares$87.5 Million5.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.94MShares$60.4 Million0.03% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.91B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...